Onur Hursitoglu

Kahramanmaras, Turkey

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Plasma miRNA Profiles in Chronically Treated Bipolar Disorder Patients: A Case-Control Study.

Plasma miRNA Profiles in Chronically Treated Bipolar Disorder Patients: A Case-Control Study.

Journal: Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology

Published: May 15, 2025

Serum Nox1 and Gper Levels in Patients With Generalized Anxiety Disorder: A Cross-Sectional Study in Turkiye.

Serum Nox1 and Gper Levels in Patients With Generalized Anxiety Disorder: A Cross-Sectional Study in Turkiye.

Journal: Brain and behavior

Published: June 11, 2024

Psychometric properties of the Turkish reduced morningness and eveningness questionnaire.

Psychometric properties of the Turkish reduced morningness and eveningness questionnaire.

Journal: Chronobiology international

Published: April 17, 2024

Validity and Reliability of the Turkish Version of the Sleep Condition Indicator: A Clinical Screening Instrument Based on the DSM-5 Criteria for Insomnia.

Validity and Reliability of the Turkish Version of the Sleep Condition Indicator: A Clinical Screening Instrument Based on the DSM-5 Criteria for Insomnia.

Journal: Nature and science of sleep

Published: August 03, 2023

Type D personality to insomnia: Sleep reactivity, sleep effort, and sleep hygiene as mediators.

Type D personality to insomnia: Sleep reactivity, sleep effort, and sleep hygiene as mediators.

Journal: Frontiers in psychiatry

Published: February 07, 2023

Adaptation and Validation of the Turkish Version of the Ford Insomnia Response to Stress Test in University Students.

Adaptation and Validation of the Turkish Version of the Ford Insomnia Response to Stress Test in University Students.

Journal: Nature and science of sleep

Published: December 02, 2022

Serum NOX1 and Raftlin as new potential biomarkers of Major Depressive Disorder: A study in treatment-naive first episode patients.

Serum NOX1 and Raftlin as new potential biomarkers of Major Depressive Disorder: A study in treatment-naive first episode patients.

Journal: Progress in neuro-psychopharmacology & biological psychiatry

Published: October 03, 2022

Serum Levels of 8-Iso-Prostaglandin F2α and Raftlin in Patients with Generalized Anxiety Disorder.

Serum Levels of 8-Iso-Prostaglandin F2α and Raftlin in Patients with Generalized Anxiety Disorder.

Journal: Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology

Published: August 11, 2022

Serum NOX1 and Raftlin as New Potential Biomarkers of Interest in Schizophrenia: A Preliminary Study.

Serum NOX1 and Raftlin as New Potential Biomarkers of Interest in Schizophrenia: A Preliminary Study.

Journal: Neuropsychiatric disease and treatment

Published: August 09, 2022

Validity and reliability of the Turkish version of the Glasgow Sleep Effort Scale.

Validity and reliability of the Turkish version of the Glasgow Sleep Effort Scale.

Journal: Sleep medicine

Published: May 17, 2022

Psychometric properties of the Turkish version of the Anxiety and Preoccupation about Sleep Questionnaire in clinical and non-clinical samples.

Psychometric properties of the Turkish version of the Anxiety and Preoccupation about Sleep Questionnaire in clinical and non-clinical samples.

Journal: Sleep science (Sao Paulo, Brazil)

Published: February 10, 2021

Diagnostic Performance of Increased Malondialdehyde Level and Oxidative Stress in Patients with Schizophrenia.

Diagnostic Performance of Increased Malondialdehyde Level and Oxidative Stress in Patients with Schizophrenia.

Journal: Noro psikiyatri arsivi

Published: August 08, 2020

Showing 1-12 of 13

Last Updated: 09/26/2026